*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Glipizide</strong> is a second-generation sulfonylurea antidiabetic agent manufactured via condensation of 5-methyl-2-p-tolylamino-benzimidazole with specific reagents. Its molecular formula is C<sub>21</sub>H<sub>27</sub>N<sub>5</sub>O<sub>4</sub>S and CAS number is <strong>29098-67-9</strong>.</p>
<h3>Application</h3>
<ul>
<li>Pharmaceutical manufacturing for type 2 diabetes management.</li>
<li>Active Pharmaceutical Ingredient (API) supply for oral tablet production.</li>
<li>Research applications in metabolic syndrome studies.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe renal impairment. Store in tight, light-resistant containers at controlled room temperature (20°C to 25°C). Handle with PPE to avoid inhalation or skin contact during synthesis.</p>